Dynamic Perfusion Technology Intensifies Upstream Cell Culture Operations, Boosting Product Quality, Yield, and Facility Utilization

September 13, 2026

Bioprocess Online USA

Overview

Dynamic perfusion technology is emerging as an innovative approach to streamline continuous cell culture processes, significantly enhancing product quality, yield, and facility utilization. This method eliminates the need for routine adjustments to cell bleed and perfusion rates, thereby reducing operational complexity while retaining the benefits of process intensification. These improvements promise greater efficiency and productivity in biopharmaceutical manufacturing, leading to more cost-effective production systems.

In Depth

Key Findings

Dynamic perfusion technology represents a groundbreaking method that significantly intensifies upstream operations in cell culture, streamlining continuous cell culture processes. This approach demonstrably improves product quality, production yield, and manufacturing facility utilization, while also offering substantial benefits by reducing the operational burden of process management.

Technical and Clinical Details

Compared to conventional perfusion culture, dynamic perfusion possesses the ability to autonomously adapt to changes in cell concentration and media composition. This eliminates the need for routine manual adjustments to cell bleed and perfusion rates. In-process sensors and advanced control algorithms continuously monitor cell growth and metabolic activity in real-time, automatically executing optimal perfusion strategies. For example, when cell concentration exceeds a predefined threshold, the system automatically initiates cell bleed to maintain an optimal culture environment. This automated control reduces the risk of human error and enhances process robustness and reproducibility. Consequently, bioreactor uptime is maximized, leading to a substantial increase in volumetric productivity compared to traditional batch culture and static perfusion.

Background and Industry Context

Driven by increasing market demand and pressure for cost reduction, the biopharmaceutical manufacturing industry is accelerating its transition towards process intensification and continuous manufacturing. Perfusion culture has contributed to this trend by enabling high-cell-density cultivation and improving productivity per reactor volume. However, conventional perfusion systems often require complex operation and frequent intervention, which can be barriers to adoption. Dynamic perfusion addresses these operational challenges, making the benefits of continuous biomanufacturing more accessible and thus driving industry transformation. Its application is particularly anticipated in the manufacturing of expensive cell and gene therapy products and biosimilars, where efficient production is critical.

Strategic Significance and Outlook

Dynamic perfusion technology holds the potential to become a cornerstone of future biopharmaceutical manufacturing platforms. Further development of this technology will facilitate easier integration into fully continuous, end-to-end processes, enabling reduced manufacturing footprints, optimized capital expenditures (CAPEX), and flexible production scale-up. Furthermore, the combination of real-time process data with AI and machine learning is expected to lead to even greater process optimization and predictive capabilities. This will enable faster market entry for new drugs and broader patient access, contributing to the overall competitiveness of the biopharmaceutical industry.

Source: https://www.bioprocessonline.com/doc/intensification-of-upstream-operations-with-dynamic-perfusion-0001

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.